Pharmacopeia will receive $5 million payment from GlaxoSmithKline in connection with two companies’ product development and commercialization agreement from March 2006. This is the second $5 million payment Pharmacopeia has received. This payment was triggered by Pharmacopeia’s completion of early discovery activities. Pharmacopeia is eligible to receive a third $5 million payment based on additional early discovery activities. Pharmacopeia is also entitled to milestone paymen...